Literature DB >> 11602343

Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing.

A C Goldstrohm1, A L Greenleaf, M A Garcia-Blanco.   

Abstract

Nascent transcripts are the true substrates for many splicing events in mammalian cells. In this review we discuss transcription, splicing, and alternative splicing in the context of co-transcriptional processing of pre-mRNA. The realization that splicing occurs co-transcriptionally requires two important considerations: First, the cis-acting elements in the splicing substrate are synthesized at different times in a 5' to 3' direction. This dynamic view of the substrate implies that in a 100 kb intron the 5' splice site will be synthesized as much as an hour before the 3' splice site. Second, the transcription machinery and the splicing machinery, which are both complex and very large, are working in close proximity to each other. It is therefore likely that these two macromolecular machines interact, and recent data supporting this notion is discussed. We propose a model for co-transcriptional pre-mRNA processing that incorporates the concepts of splice site-tethering and dynamic exon definition. Also, we present a dynamic view of the alternative splicing of FGF-R2 and suggest that this view could be generally applicable to many regulated splicing events.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602343     DOI: 10.1016/s0378-1119(01)00695-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  61 in total

Review 1.  Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing.

Authors:  Mariano A Garcia-Blanco
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 2.  Emerging roles of BRCA1 alternative splicing.

Authors:  T I Orban; E Olah
Journal:  Mol Pathol       Date:  2003-08

3.  Cotranscriptional recruitment of the U1 snRNP to intron-containing genes in yeast.

Authors:  Kimberly M Kotovic; Daniel Lockshon; Lamia Boric; Karla M Neugebauer
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

4.  Minimal introns are not "junk".

Authors:  Jun Yu; Zhiyong Yang; Miho Kibukawa; Marcia Paddock; Douglas A Passey; Gane Ka-Shu Wong
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

5.  RNA editing of a miRNA precursor.

Authors:  Daniel J Luciano; Henry Mirsky; Nicholas J Vendetti; Stefan Maas
Journal:  RNA       Date:  2004-08       Impact factor: 4.942

6.  The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo.

Authors:  Kai-Ti Lin; Ruei-Min Lu; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

7.  TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.

Authors:  Marta Montes; Alexandre Cloutier; Noemí Sánchez-Hernández; Laetitia Michelle; Bruno Lemieux; Marco Blanchette; Cristina Hernández-Munain; Benoit Chabot; Carlos Suñé
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

8.  Total RNA sequencing reveals nascent transcription and widespread co-transcriptional splicing in the human brain.

Authors:  Adam Ameur; Ammar Zaghlool; Jonatan Halvardson; Anna Wetterbom; Ulf Gyllensten; Lucia Cavelier; Lars Feuk
Journal:  Nat Struct Mol Biol       Date:  2011-11-06       Impact factor: 15.369

Review 9.  A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts.

Authors:  Didier Auboeuf; Dennis H Dowhan; Martin Dutertre; Natalia Martin; Susan M Berget; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

10.  Cellular splicing and transcription regulatory protein p32 represses adenovirus major late transcription and causes hyperphosphorylation of RNA polymerase II.

Authors:  Christina Ohrmalm; Göran Akusjärvi
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.